Antibody Citations

OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.

Search citations by gene symbols or target names

Here are some of the recent papers making use of OriGene products by fellow researchers.

Target Research Paper Journal Product SKU
LGR5 Selection of a Malignant Subpopulation from a Colorectal Cancer Cell Line bioRxiv, 2019 Mar Antibody TA503316S
LGR5 Selection of a Malignant Subpopulation from a Colorectal Cancer Cell Line bioRxiv, 2019 Mar Antibody TA503316
LGR5 Acute exposure to deoxynivalenol inhibits porcine enteroid activity via suppression of the Wnt/β-catenin pathway Toxicology Letters, 2019 Jan Antibody TA503316
LGR5 Acute exposure to deoxynivalenol inhibits porcine enteroid activity via suppression of the Wnt/β-catenin pathway Toxicology Letters, 2019 Jan Antibody TA503316S
LGR5 Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers Oncogene, 2018 Dec Antibody TA400001
LGR5 LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients J. Exp. Clin. Cancer Res., 2018 Sep Antibody TA502948
LGR5 LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients J. Exp. Clin. Cancer Res., 2018 Sep Antibody TA502948S
LGR5 LGR5 regulates gastric adenocarcinoma cell proliferation and invasion via activating Wnt signaling pathway Oncogenesis, 2018 Aug Antibody TA502946
LGR5 Resveratrol reduces senescence-associated secretory phenotype by SIRT1/NF-κB pathway in gut of the annual fish Nothobranchius guentheri Fish Shellfish Immunol., 2018 Jun Antibody TA503316S
LGR5 Resveratrol reduces senescence-associated secretory phenotype by SIRT1/NF-κB pathway in gut of the annual fish Nothobranchius guentheri Fish Shellfish Immunol., 2018 Jun Antibody TA503316
LGR5 NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells PLoS ONE, 2018 Apr Antibody TA503316S
LGR5 NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells PLoS ONE, 2018 Apr Antibody TA503316
LGR5 Synergistic actions of FGF2 and bone marrow transplantation mitigate radiation-induced intestinal injury Cell Death Dis, 2018 Mar Antibody UM870102
LGR5 Liver damage, proliferation, and progenitor cell markers in experimental necrotizing enterocolitis J. Pediatr. Surg., 2018 Feb Antibody TA503316S
LGR5 Liver damage, proliferation, and progenitor cell markers in experimental necrotizing enterocolitis J. Pediatr. Surg., 2018 Feb Antibody TA503316
LGR5 Identification of PMN-released Mutagenic Factors in a Co-culture Model for Colitis-associated Cancer Carcinogenesis, 2017 Nov Antibody TA503316
LGR5 Identification of PMN-released Mutagenic Factors in a Co-culture Model for Colitis-associated Cancer Carcinogenesis, 2017 Nov Antibody TA503316S
LGR5 Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases J Proteomics, 2017 Jun Antibody TA503316S
LGR5 Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases J Proteomics, 2017 Jun Antibody TA503316
LGR5 Cluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoids Cancer Sci., 2017 Apr Antibody TA400001
LGR5 Role of Wnt/β-catenin signaling pathway in the repair of intestinal mucosa associated with crypt stem cell in a rat model of abdominal compartment syndrome Int J Clin Exp Patho, 2017 Feb Antibody CF503155
LGR5 LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1 PLoS ONE, 2016 Dec Antibody TA503316
LGR5 LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1 PLoS ONE, 2016 Dec Antibody TA503316S
LGR5 Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase Oncotarget, 2016 Dec Antibody TA503316S
LGR5 Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase Oncotarget, 2016 Dec Antibody TA503316
LGR5 A recellularized human colon model identifies cancer driver genes Nat. Biotechnol., 2016 Jul Antibody TA503316S
LGR5 A recellularized human colon model identifies cancer driver genes Nat. Biotechnol., 2016 Jul Antibody TA503316
LGR5 Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer Br. J. Cancer, 2016 May Antibody TA503316S
LGR5 RSPO2 enriches LGR5(+) spheroid colon cancer stem cells and promotes its metastasis by epithelial-mesenchymal transition Am J Transl Res, 2016 May Antibody TA400001
LGR5 Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer Br. J. Cancer, 2016 May Antibody TA503316
LGR5 Evaluation of LGR5 protein expression in colon cancer stem cells AACR 2016 Abstract, 2016 Apr Antibody UM800104
LGR5 Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures PLoS ONE, 2015 Nov Antibody TA400001
LGR5 Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures PLoS ONE, 2015 Nov Antibody CF502946
LGR5 Development and Evaluation of Highly Specific Monoclonal Antibodies against Human LGR5 for the Identification of Colon Cancer Stem Cells The FASEB Journal, 2015 Apr Antibody UM800104
LGR5 LGR5 activates non-canonical Wnt-signaling and inhibits aldosterone production in the human adrenal J. Clin. Endocrinol. Metab., 2015 Apr Antibody TA503316
LGR5 Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas Am. J. Pathol., 2015 Apr Antibody TA301323
LGR5 LGR5 activates non-canonical Wnt-signaling and inhibits aldosterone production in the human adrenal J. Clin. Endocrinol. Metab., 2015 Apr Antibody TA503316S
LGR5 Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1. Cancer letters, 2015 Mar Antibody CF502946
LGR5 A Human Colonic Crypt Culture System to Study Regulation of Stem Cell-Driven Tissue Renewal and Physiological Function Methods Mol. Biol., 2015 Mar Antibody TA400001
LGR5 Postnatal epithelium and mesenchyme stem/progenitor cells in bioengineered amelogenesis and dentinogenesis Biomaterials, 2015 Feb Antibody TA502946
LGR5 B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor ONCOLOGY LETTERS, 2015 Jan Antibody TA400001
LGR5 The use of murine-derived fundic organoids in studies of gastric physiology J. Physiol. (Lond.), 2015 Jan Antibody TA400001
LGR5 The Role of Fn14 in Acute Alcoholic Steatohepatitis in Mice Am. J. Physiol. Gastrointest. Liver Physiol., 2014 Dec Antibody TA301323
LGR5 Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression Carcinogenesis, 2014 Oct Antibody TA301323
LGR5 CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression J. Cancer Res. Clin. Oncol. July 2014, 2014 Jul Antibody TA503316
LGR5 CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression J. Cancer Res. Clin. Oncol. July 2014, 2014 Jul Antibody TA503316S
LGR5 LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/ß-catenin signaling pathway in colorectal cancer cells Cell. Signal. July 2014, 2014 Jul Antibody TA503316S
LGR5 LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/ß-catenin signaling pathway in colorectal cancer cells Cell. Signal. July 2014, 2014 Jul Antibody TA503316
LGR5 Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway Exp. Cell Res., Feb 2014., 2014 Feb Antibody TA301323
LGR5 TWEAK/Fn14 Signaling Is Required for Liver Regeneration after Partial Hepatectomy in Mice PLoS ONE, Jan 2014., 2014 Jan Antibody TA301323